Concepedia

Shanhe Yu

SY

Statistics

Publications

21

Citations

600

H-Index

16

Active since

2001

Affiliations

Shanghai Institute of Hematology(Current)

Shanghai Jiao Tong University

Ruijin Hospital

Harvard University

Dana-Farber Cancer Institute

Shanhe Yu is an author at Shanghai Institute of Hematology specializing in life sciences, gene expression, and medicine.

ORCID

Publications per year

2001–2024

21

Publications

21

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial

Jie Xu, Baiyan Wang, Shanhe Yu et al. · Journal of Hematology & Oncology · 2024 · 79 citations · Full text

, , +15

Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of <i>MMP9</i> and <i>ABCG2</i>

Ying Huang, Shanhe Yu, Wenxuan Zhen et al. · Theranostics · 2021 · 71 citations · Full text

, , +16

JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML

Shanhe Yu, Kang-Yong Zhu, Juan Chen et al. · Nature Communications · 2018 · 67 citations · Full text

, , +17

KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma

Bo Zhang, Binghai Zhou, Min Xiao et al. · Frontiers in Oncology · 2020 · 40 citations · Full text

, , +14

A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML

He‐Zhou Guo, Rui-Xue Feng, Yanjie Zhang et al. · Cell Reports Medicine · 2024 · 40 citations · Full text

, , +17

1–5 of 21